Search Results 41-50 of 154 for 株洲大量收U盾卡(TF:@yifushouu).kgptm
About this study. The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is ...
About this study. The purpose of the trial is to establish the tolerability of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors.
Porche K, Wu KY, Spinner RJ. Superficial peroneal to tibial nerve transfer for restoring plantar flexion in partial sciatic nerve injuries: illustrative ...
A Magnussen R, Binzel K, Zhang J, Wei W, U Knopp M, C Flanigan D, E Hewett T, C Kaeding C, V Knopp M. ACL graft metabolic activity assessed by (18)FDG PET ...
Glaucoma is the leading cause of irreversible blindness with 80 million patients affected worldwide. Mayo Clinic researchers are focused on developing ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...
Nagao B, Yuan S, Lu Q. Drug-induced hemolytic anemia and Thrombocytopenia. Check Sample of American Society of Clinical Pathology, Transfusion Medicine. 2011; ...
The purpose of this study is assess the pharmacodynamics, pharmacokinetics, safety and effectiveness of two different doses of Tocilizumab (TCZ) in combination ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift that can go twice as far to advance healthcare research.